These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

365 related items for PubMed ID: 18049781

  • 1. Source to sink tracking of selected human pharmaceuticals from two Oslo city hospitals and a wastewater treatment works.
    Thomas KV, Dye C, Schlabach M, Langford KH.
    J Environ Monit; 2007 Dec; 9(12):1410-8. PubMed ID: 18049781
    [Abstract] [Full Text] [Related]

  • 2. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L, Smyth SA, Sarafin K, Kleywegt S, Toito J, Peart T, Lee B, Servos M, Beland M, Seto P.
    Sci Total Environ; 2006 Aug 31; 367(2-3):544-58. PubMed ID: 16697441
    [Abstract] [Full Text] [Related]

  • 3. Diurnal variations in the occurrence and the fate of hormones and antibiotics in activated sludge wastewater treatment in Oslo, Norway.
    Plósz BG, Leknes H, Liltved H, Thomas KV.
    Sci Total Environ; 2010 Mar 15; 408(8):1915-24. PubMed ID: 20156636
    [Abstract] [Full Text] [Related]

  • 4. Determination of pharmaceutical compounds in hospital effluents and their contribution to wastewater treatment works.
    Langford KH, Thomas KV.
    Environ Int; 2009 Jul 15; 35(5):766-70. PubMed ID: 19336268
    [Abstract] [Full Text] [Related]

  • 5. Dynamics of steroid estrogen daily concentrations in hospital effluent and connected waste water treatment plant.
    Avberšek M, Sömen J, Heath E.
    J Environ Monit; 2011 Aug 15; 13(8):2221-6. PubMed ID: 21727965
    [Abstract] [Full Text] [Related]

  • 6. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
    Bendz D, Paxéus NA, Ginn TR, Loge FJ.
    J Hazard Mater; 2005 Jul 15; 122(3):195-204. PubMed ID: 15967274
    [Abstract] [Full Text] [Related]

  • 7. Sources of pharmaceutical pollution in the New York City Watershed.
    Palmer PM, Wilson LR, O'Keefe P, Sheridan R, King T, Chen CY.
    Sci Total Environ; 2008 May 01; 394(1):90-102. PubMed ID: 18280543
    [Abstract] [Full Text] [Related]

  • 8. Hospital effluent: investigation of the concentrations and distribution of pharmaceuticals and environmental risk assessment.
    Verlicchi P, Al Aukidy M, Galletti A, Petrovic M, Barceló D.
    Sci Total Environ; 2012 Jul 15; 430():109-18. PubMed ID: 22634557
    [Abstract] [Full Text] [Related]

  • 9. Input of selected human pharmaceutical metabolites into the Norwegian aquatic environment.
    Langford K, Thomas KV.
    J Environ Monit; 2011 Feb 15; 13(2):416-21. PubMed ID: 21152649
    [Abstract] [Full Text] [Related]

  • 10. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment.
    Jelic A, Gros M, Ginebreda A, Cespedes-Sánchez R, Ventura F, Petrovic M, Barcelo D.
    Water Res; 2011 Jan 15; 45(3):1165-76. PubMed ID: 21167546
    [Abstract] [Full Text] [Related]

  • 11. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline.
    Grung M, Källqvist T, Sakshaug S, Skurtveit S, Thomas KV.
    Ecotoxicol Environ Saf; 2008 Oct 15; 71(2):328-40. PubMed ID: 18068226
    [Abstract] [Full Text] [Related]

  • 12. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain).
    Santos JL, Aparicio I, Alonso E.
    Environ Int; 2007 May 15; 33(4):596-601. PubMed ID: 17084895
    [Abstract] [Full Text] [Related]

  • 13. Occurrence of antibiotics in hospital, residential, and dairy effluent, municipal wastewater, and the Rio Grande in New Mexico.
    Brown KD, Kulis J, Thomson B, Chapman TH, Mawhinney DB.
    Sci Total Environ; 2006 Aug 01; 366(2-3):772-83. PubMed ID: 16313947
    [Abstract] [Full Text] [Related]

  • 14. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant.
    Carballa M, Omil F, Lema JM, Llompart M, García-Jares C, Rodríguez I, Gómez M, Ternes T.
    Water Res; 2004 Jul 01; 38(12):2918-26. PubMed ID: 15223286
    [Abstract] [Full Text] [Related]

  • 15. Occurrence of pharmaceuticals and personal care products along the West Prong Little Pigeon River in east Tennessee, USA.
    Yu CP, Chu KH.
    Chemosphere; 2009 Jun 01; 75(10):1281-6. PubMed ID: 19395062
    [Abstract] [Full Text] [Related]

  • 16. Occurrence and removal of pharmaceuticals in wastewater treatment plants at the Spanish Mediterranean area of Valencia.
    Gracia-Lor E, Sancho JV, Serrano R, Hernández F.
    Chemosphere; 2012 Apr 01; 87(5):453-62. PubMed ID: 22221664
    [Abstract] [Full Text] [Related]

  • 17. Carbamazepine, diclofenac, ibuprofen and bezafibrate--investigations on the behaviour of selected pharmaceuticals during wastewater treatment.
    Strenn B, Clara M, Gans O, Kreuzinger N.
    Water Sci Technol; 2004 Apr 01; 50(5):269-76. PubMed ID: 15497857
    [Abstract] [Full Text] [Related]

  • 18. Populations of antibiotic-resistant coliform bacteria change rapidly in a wastewater effluent dominated stream.
    Akiyama T, Savin MC.
    Sci Total Environ; 2010 Nov 15; 408(24):6192-201. PubMed ID: 20888028
    [Abstract] [Full Text] [Related]

  • 19. Drugs, diagnostic agents and disinfectants in wastewater and water--a review.
    Kümmerer K.
    Schriftenr Ver Wasser Boden Lufthyg; 2000 Nov 15; 105():59-71. PubMed ID: 10842795
    [Abstract] [Full Text] [Related]

  • 20. Determining the fraction of pharmaceutical residues in wastewater originating from a hospital.
    Ort C, Lawrence MG, Reungoat J, Eaglesham G, Carter S, Keller J.
    Water Res; 2010 Jan 15; 44(2):605-15. PubMed ID: 19717180
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.